Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Must Reads In Liposarcoma

Liposarcoma for November/December 2018

Type and rate of clonal evolution vary widely in sarcoma pathogenetic subgroups, Hofvander J et al. Nature Communications 10 Sept. 2018. https://doi.org/10.1038/s41467-018-06098-0

More must reads

Liposarcoma for September/October 2018

High recurrence rate after pancreaticoduodenectomy for primary retroperitoneal sarcoma, Tseng W et al. European Journal of Surgical Oncology 2018 (44): June; 810-815.

Radiotherapy benefits in surgically-treated retroperitoneal sarcoma, Nazzani S et al. Radiotherapy and Oncology 2018: 127; 318-325. https://doi.org/10.1016/j.radonc.2018.03.027

More must reads

Liposarcoma for July/August 2018

Trabectedin extended PFS in advanced liposarcoma, Le Cesne A et al. ASCO 2018. Abstract 11508.

More must reads